Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Dieras V; Curigliano G; Martin M; Lerebours F; Tsurutani J; Savard MF; Jerzak KJ; Hu X; Martins de Aquino Pimentel LC; O'Sullivan CC; Tokunaga E; Okines A; Huang CS; Jacot W; Sohn J; Cronemberger Silva E; Mueller V; Yang S; Granata G; Shen Q; Santarpia L; Hamilton E.

HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.

JOURNAL OF CLINICAL ONCOLOGY. ; : [doi:10.1200/JCO-25-02600]

Fong PC; Kwiatkowski M; Mosca A; Valderrama BP; Li C; Huang YH; Zedan AH; Kuc K; Wiechno P; Laguerre B; Gonzalez-Billalabeitia E; Osipov M; Sener Dede D; Goh JC; Daugaard G; Zhu P; Imai K; Liu Y; Arranz Arija JA.

Vibostolimab Coformulated with Pembrolizumab in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: KEYNOTE-365 Cohort G.

European Urology Focus. ; : [doi:10.1016/j.euf.2025.07.018]